Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Daily News

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Michael O'Riordan

April 30, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

Michael O'Riordan

February 22, 2019

News Daily News

Ultrathin-Strut DES Outperform Second-Gen DES at 1 Year: Meta-analysis

Caitlin E. Cox

June 28, 2018

News Daily News

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

Yael L. Maxwell

February 26, 2018

News Daily News

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

Shelley Wood

July 21, 2017

News Daily News

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Michael O'Riordan

February 16, 2017

News Daily News

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

August 27, 2015

News Daily News

BRS Strut Width Tied to Increased Periprocedural MI

June 02, 2015

News Daily News

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

April 29, 2015

News Daily News

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

Yael L. Maxwell

January 28, 2015

News Daily News

Small OCT Study Suggests Favorable Long-term Response to Bioresorbable Scaffold

December 04, 2014

News Daily News

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

November 06, 2014

News Daily News

OCT Analysis Reveals Pattern of Delayed DES Coverage in CTOs

October 17, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

News Daily News

Autopsy Study Identifies Lesion, Procedural Traits Linked to Early Stent Thrombosis

April 23, 2014

News Daily News

Bioresorbable Scaffold Performs Well in Select STEMI Patients

January 22, 2014

News Daily News

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Yael L. Maxwell

January 09, 2014

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

Advertisement

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

TCTMD’s Top 10 Most Popular Stories for February 2019

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

Ultrathin-Strut DES Outperform Second-Gen DES at 1 Year: Meta-analysis

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

BRS Strut Width Tied to Increased Periprocedural MI

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

Small OCT Study Suggests Favorable Long-term Response to Bioresorbable Scaffold

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

OCT Analysis Reveals Pattern of Delayed DES Coverage in CTOs

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Autopsy Study Identifies Lesion, Procedural Traits Linked to Early Stent Thrombosis

Bioresorbable Scaffold Performs Well in Select STEMI Patients

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content